THE EFFECT OF LACTOBACILLUS REUTERI-CONTAINING QUADRUPLE THERAPY IN FIRST-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION: A SINGLE-CENTER OPEN-LABEL RANDOMIZED CONTROLLED STUDY

Cailing Li  1     Baojun Suo  1     XUELI TIAN  1     Yuxin Zhang  1     Xinlu Ren  1     ZhiQiang Song  1    
1 Peking University Third Hospital, Beijing, China

Session
H. pylori (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing